Table 1. Baseline characteristics of the study participants (n = 848).
Table 1
Baseline characteristics of the study sample (N = 848).
| Mean (SD) | Median (IQR) | Range |
Age (years old) | 32.72 (4.71) | 32.43 (29.07, 36.13) | 20.96–47.40 |
BMI (kg/m2) | 24.16 (4.01) | 24.17 (21.22, 26.56) | 15.07–39.90 |
Gravidity | 1.20 (1.11) | 1.0 (0, 2.0) | 0–7 |
Parity | 0.53 (0.53) | 1.0 (0, 1.0) | 0–3 |
EQ index valuea | 0.836 (0.173) | 0.814 (0.740, 1.000) | -0.111-1.000 |
EQ-VASb | 87.80 (9.36) | 90 (80, 95) | 40–100 |
a EuroQol index value |
b EuroQol-visual analogue scale |
SD = standard deviation; IQR = interquartile range |
A total of 848 pregnant women completed the EQ-5D-5L questionnaire at least once, and 848 questionnaires were compiled and included for further analysis. Table 1 listed the baseline characteristics and overall EQ-5D-5L scores of the pregnant women. The ages of the pregnant women ranged from 20–47 (average: 32.72 ± 4.71 years). The mean pre-pregnancy BMI was 24.16 ± 4.01 kg/m2.
Table 2. EQ-VAS and EQ index value of women in different conditions cross five gestational stages.
Table 2
EQ-VAS and EQ index value of women in different conditions cross five gestational stages.
Condition | Trimester-specific | Overall |
| 1st | Early 2nd | Late 2nd | Early 3rd | Late 3rd | |
Singleton pregnancy | N = 44 | N = 109 | N = 199 | N = 244 | N = 220 | N = 816 |
EQ-VAS a | 88.77 (9.92) | 87.88 (9.53) | 88.22 (9.12) | 87.90 (8.84) | 87.34 (9.80) | 87.87 (9.31) |
EQ index value b | 0.773 (0.349) | 0.888 (0.122) | 0.865 (0.136) | 0.831 (0.188) | 0.813 (0.145) | 0.839 (0.173) |
Multiple pregnancy | | N = 8 | N = 6 | N = 12 | N = 6 | N = 32 |
EQ-VAS a | - | 86.50 (10.18) | 90.42 (8.43) | 81.50 (10.23) | 88.75 (13.01) | 85.92 (10.59) |
EQ index value b | - | 0.850 (0.131) | 0.805 (0.126) | 0.711 (0.147) | 0.681 (0.122) | 0.758 (0.145) |
Primipara | N = 25 | N = 57 | N = 100 | N = 118 | N = 112 | N = 412 |
EQ-VAS a | 86.54 (10.96) | 87.75 (9.46) | 86.84 (9.56) | 86.41 (8.90) | 87.29 (10.47) | 86.95 (9.67) |
EQ index value b | 0.776 (0.349) | 0.874 (0.125) | 0.835 (0.146) | 0.797 (0.207) | 0.801 (0.143) | 0.817 (0.182) |
Multipara | N = 19 | N = 60 | N = 105 | N = 138 | N = 114 | N = 436 |
EQ-VAS a | 91.58 (7.83) | 87.82 (9.68) | 89.65 (8.44) | 88.65 (8.94) | 87.36 (9.23) | 88.58 (8.98) |
EQ index value b | 0.768 (0.359) | 0.896 (0.120) | 0.890 (0.119) | 0.850 (0.167) | 0.817 (0.148) | 0.854 (0.162) |
Smoking partner | N = 6 | N = 19 | N = 33 | N = 35 | N = 30 | N = 123 |
EQ-VAS a | 94.17 (2.04) | 87.24 (7.99) | 89.65 (7.56) | 89.44 (7.46) | 88.31 (9.80) | 89.12 (8.05) |
EQ index value b | 0.926 (0.118) | 0.881 (0.119) | 0.854 (0.131) | 0.835 (0.209) | 0.811 (0.143) | 0.846 (0.158) |
Non-smoking partner | N = 38 | N = 96 | N = 170 | N = 219 | N = 195 | N = 718 |
EQ-VAS a | 87.89 (10.42) | 88.21 (9.69) | 87.99 (9.34) | 87.28 (9.18) | 87.23 (9.91) | 87.59 (9.54) |
EQ index value b | 0.748 (0.368) | 0.891 (0.121) | 0.865 (0.137) | 0.824 (0.186) | 0.809 (0.146) | 0.834 (0.176) |
Drunk partner | N = 1 | N = 7 | N = 19 | N = 20 | N = 21 | N = 68 |
EQ-VAS a | 90.0 | 91.93 (5.79) | 87.0 (6.09) | 87.18 (11.35) | 86.89 (10.51) | 87.57 (9.21) |
EQ index value b | 0.740 | 0.903 (0.124) | 0.838 (0.109) | 0.865 (0.140) | 0.779 (0.093) | 0.833 (0.121) |
Sober partner | N = 43 | N = 109 | N = 184 | N = 236 | N = 204 | N = 776 |
EQ-VAS a | 88.74 (10.04) | 87.67 (9.59) | 88.39 (9.34) | 87.66 (8.77) | 87.42 (9.84) | 87.83 (9.37) |
EQ index value b | 0.773 (0.353) | 0.886 (0.122) | 0.866 (0.138) | 0.822 (0.191) | 0.812 (0.150) | 0.836 (0.177) |
Cardio diseases | N = 0 | N = 3 | N = 4 | N = 7 | N = 2 | N = 16 |
EQ-VASa | - | 88.33 (7.64) | 81.25 (10.31) | 89.29 (7.87) | 67.5 (38.89) | 84.38 (14.48) |
EQ index valueb | - | 0.852 (0.137) | 0.850 (0.109) | 0.884 (0.153) | 0.748 (0.356) | 0.853 (0.157) |
Hepatitis B | N = 0 | N = 3 | N = 4 | N = 3 | N = 8 | N = 18 |
EQ-VASa | - | 95.0 (5.0) | 92.5 (11.9) | 80.0 (17.32) | 87.77 (6.81) | 88.73 (10.32) |
EQ index valueb | - | 0.881 (0.103) | 0.911 (0.103) | 0.762 (0.073) | 0.831 (0.129) | 0.846 (0.115) |
GDMc | N = 1 | N = 13 | N = 26 | N = 40 | N = 34 | N = 114 |
EQ-VASa | 70.0 | 87.54 (12.53) | 87.40 (11.01) | 87.00 (10.89) | 87.88 (12.11) | 86.97 (11.39) |
EQ index valueb | 0.673 | 0.906 (0.129) | 0.850 (0.127) | 0.826 (0.134) | 0.857 (0.143) | 0.849 (0.135) |
Scar uterus pregnancy | N = 6 | N = 14 | N = 46 | N = 72 | N = 31 | N = 169 |
EQ-VASa | 92.5 (7.58) | 85.11 (13.82) | 89.24 (9.76) | 87.78 (10.41) | 90.16 (6.57) | 50–100 |
EQ index valueb | 0.760 (0.446) | 0.930 (0.116) | 0.895 (0.112) | 0.843 (0.162) | 0.814 (0.137) | -0.111-1.000 |
Non-complications | N = 7 | N = 33 | N = 68 | N = 108 | N = 70 | N = 286 |
EQ-VASa | 89.29 (10.97) | 88.56 (10.27) | 88.71 (9.80) | 87.67 (10.52) | 87.93 (11.47) | 50.0–100.0 |
EQ index valueb | 0.748 (0.409) | 0.909 (0.119) | 0.877 (0.123) | 0.829 (0.179) | 0.834 (0.148) | -0.111–1.000 |
a EuroQol-visual analogue scale |
b EuroQol index value |
c gestational diabetes mellitus |
d preeclampsia |
e including thyroid diseases, thalassemia, obesity, etc. |
Table 2 shows the EQ-VAS and EQ index value of pregnant women in different conditions, with or without complications. There are 3,125 (equals 5 to the power of 5) types of possible response patterns. Among 848 questionnaires in this study, 72 types of patterns occurred at least once. 38.8% of our sample (n = 329) reported the optimal response pattern ‘11111’, followed by the pattern ‘11121’ reported by 145 pregnant women (17.1%).
Table 3. Frequency (percentage) of reporting levels 1 to 5 in EQ-5D dimensions across five gestational stages.
Table 3
Frequency (percentage) of reporting levels 1 to 5 in EQ-5D dimensions across five gestational stages.
EQ-5D DIMENSION | Trimester-specific | Overall (N = 848) |
1st (n = 44) | Early 2nd (n = 117) | Late 2nd (n = 205) | Early 3rd (n = 256) | Late 3rd (n = 226) |
Mobility | Level 1 | 34 (77.3) | 109 (93.2) | 185 (90.2) | 194 (75.8) | 162 (71.7) | 684 (80.7) |
Level 2 | 4 (9.1) | 7 (6.0) | 19 (9.3) | 50 (19.5) | 55 (24.3) | 135 (15.9) |
Level 3 | 0 | 1 (0.9) | 0 | 5 (2.0) | 6 (2.7) | 12 (1.4) |
Level 4 | 1 (2.3) | 0 | 0 | 1 (0.4) | 1 (0.4) | 3 (0.4) |
Level 5 | 5 (11.4) | 0 | 1 (0.5) | 6 (2.3) | 2 (0.9) | 14 (1.7) |
Self-care | Level 1 | 37 (84.1) | 115 (98.3) | 193 (94.1) | 224 (87.5) | 196 (86.7) | 765 (90.2) |
Level 2 | 1 (2.3) | 2 (1.7) | 11 (5.4) | 24 (9.4) | 25 (11.1) | 63 (7.4) |
Level 3 | 0 | 0 | 0 | 1 (0.4) | 2 (0.9) | 3 (0.4) |
Level 4 | 0 | 0 | 0 | 0 | 2 (0.9) | 2 (0.2) |
Level 5 | 6 (13.6) | 0 | 1 (0.5) | 7 (2.7) | 1 (0.4) | 15 (1.8) |
Usual activity | Level 1 | 35 (79.5) | 110 (94.0) | 179 (87.3) | 206 (80.5) | 175 (77.4) | 705 (83.1) |
Level 2 | 3 (6.8) | 7 (6.0) | 24 (11.7) | 41 (16.0) | 43 (19.0) | 118 (13.9) |
Level 3 | 0 | 0 | 1 (0.5) | 3 (1.2) | 5 (2.2) | 9 (1.1) |
Level 4 | 1 (2.3) | 0 | 0 | 2 (0.8) | 2 (0.9) | 5 (0.6) |
Level 5 | 5 (11.4) | 0 | 1 (0.5) | 4 (1.6) | 1 (0.4) | 11 (1.3) |
Pain/ Discomfort | Level 1 | 26 (59.1) | 71 (60.7) | 118 (57.6) | 134 (52.3) | 105 (46.5) | 454 (53.5) |
Level 2 | 12 (27.3) | 46 (39.3) | 83 (40.6) | 108 (42.2) | 106 (46.9) | 355 (41.9) |
Level 3 | 0 | 0 | 3 (1.5) | 7 (2.7) | 12 (5.3) | 22 (2.6) |
Level 4 | 0 | 0 | 1 (0.5) | 3 (1.2) | 2 (0.9) | 6 (0.7) |
Level 5 | 6 (13.6) | 0 | 0 | 4 (1.6) | 1 (0.4) | 11 (1.3) |
Anxiety/ Depression | Level 1 | 28 (63.6) | 83 (70.9) | 141 (68.8) | 190 (74.2) | 151 (66.8) | 593 (69.9) |
Level 2 | 10 (22.7) | 33 (28.2) | 60 (29.3) | 55 (21.5) | 68 (30.1) | 226 (26.7) |
Level 3 | 0 | 1 (0.9) | 4 (2.0) | 2 (0.8) | 6 (2.7) | 13 (1.5) |
Level 4 | 1 (2.3) | 0 | 0 | 4 (1.6) | 0 | 5 (0.6) |
Level 5 | 5 (11.4) | 0 | 0 | 5 (2.0) | 1 (0.4) | 11 (1.3) |
1st trimester: less than 14 gestational weeks; early 2nd trimester: between 14 and 20 gestational weeks; late 2nd trimester: between 21 and 27 gestational weeks; early 3rd trimester: between 28 and 34 gestational weeks; late 3rd trimester: more than 35 gestational weeks. |
The response frequencies for each of the five dimensions, classified by gestational stages (i.e., 1st, early 2nd, late 2nd, early 3rd, and late 3rd trimesters) were listed in Table 3. Roughly one fifth (19.3%) of responders had health-related problems (levels 2–5) related to mobility, 9.8% had problems related to self-care, 16.9% had problems with usual activity, 46.5% had problems related to pain/discomfort, and 30.1% had problems related to anxiety/depression.
Table 4. Frequency (percentage) of reported problems by dimension and gestational stage.
Table 4
Frequency (percentage) of reported problems by dimension and gestational stage.
EQ-5D Dimension | Trimester (%) | Overall (N = 848) |
1st (n = 44) | Early 2nd (n = 117) | Late 2nd (n = 205) | Early 3rd (n = 256) | Late 3rd (n = 226) | |
Mobility | 10 (22.7) | 8 (6.8) | 20 (9.8) | 62 (24.2) | 64 (28.3) | 164 (19.3) |
Self-care | 7 (15.9) | 2 (1.7) | 12 (5.9) | 32 (12.5) | 30 (13.3) | 83 (9.8) |
Usual activity | 9 (20.5) | 7 (6.0) | 26 (12.7) | 50 (19.5) | 51 (22.6) | 143 (16.9) |
Pain/Discomfort | 18 (40.9) | 46 (39.3) | 87 (42.4) | 122 (47.7) | 121 (53.5) | 394 (46.5) |
Anxiety/Depression | 16 (36.4) | 34 (29.1) | 64 (31.2) | 66 (25.8) | 75 (33.2) | 255 (30.1) |
EQ-5D level 1: no problems; EQ-5D level 2–5: have problems; 1st trimester: less than 14 gestational weeks; early 2nd trimester: between 14 and 20 gestational weeks; late 2nd trimester: between 21 and 27 gestational weeks; early 3rd trimester: between 28 and 34 gestational weeks; late 3rd trimester: more than 35 gestational weeks. |
The profile of women who reported having “problems” is presented in Table 4. As noted in Table 4, problems related to pain/discomfort were the most common (46.5%); problems related to self-care were the least common (9.8%). Furthermore, more than 20% of women had problems in one of the five dimensions, except self-care, in the 1st trimester. Pregnant women who reported having problems related to mobility, usual activity and pain/discomfort were the most common during the late 3rd trimester. In contrast, problems related to self-care and anxiety/depression occurred the most frequently during the 1st trimester.
Figure 1. Profile of the proportion (%) with problems by dimension and gestational period.
As shown in Fig. 1, the proportion of women reporting problems in mobility, self-care and usual activity fell significantly from the 1st trimester to the early 2nd trimester and then increased again with gestational age. Meanwhile, there was a slight decrease from the 1st trimester to the early 2nd trimester in the proportion of reporting problems with pain/discomfort, and then increased significantly in later stages. Nevertheless, there was no evident change in proportion of women who reported problems with anxiety/depression.
Table 5. The mean and standard deviation of EQ-VAS score and EQ index values.
Table 5
The mean and standard deviation of EQ VAS score and EQ index values.
| 1st | Early 2nd | Late 2nd | Early 3rd | Late 3rd | Overall | P |
n | | 44 | 117 | 205 | 256 | 226 | 848 | |
EQ-VAS | Mean | 88.77 | 87.78 | 88.28 | 87.62 | 87.38 | 87.80 | 0.816 |
SD | 9.92 | 9.53 | 9.09 | 8.97 | 9.86 | 9.36 |
EQ index | Mean | 0.772 | 0.886 | 0.863 | 0.826 | 0.810 | 0.836 | ༜0.001* |
SD | 0.349 | 0.122 | 0.135 | 0.188 | 0.146 | 0.173 |
*p value༜0.05 indicates the statistical difference. |
In the whole sample, the mean EQ-VAS of the 848 questionnaires was 87.80 ± 9.36 (Table 5). Across the gestational stages, the mean EQ-VAS was highest in the 1st trimester (88.77 ± 9.92) and lowest in the late 3rd trimester (87.38 ± 9.86). The average overall EQ index value was 0.836 ± 0.173 (Table 5). The mean EQ index value for each consecutive pregnancy trimester was 0.772 ± 0.349, 0.886 ± 0.122, 0.863 ± 0.135, 0.826 ± 0.188, and 0.810 ± 0.146 (p value༜0.05), respectively.
Figure 2. Fluctuation of the EQ index value with gestational age.
Fluctuations in EQ index value with gestational age are shown in Fig. 2. We observed an increasing in EQ index value from the 1st to early 2nd trimester and gradual decreases thereafter.